Canada markets open in 4 hours 50 minutes

Laboratorios Farmaceuticos Rovi, S.A. (41L.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
83.60+0.95 (+1.15%)
As of 08:02AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
829,509
829,509
817,698
648,677
419,961
Cost of Revenue
337,224
337,224
298,085
263,855
178,652
Gross Profit
492,285
492,285
519,613
384,822
241,309
Operating Expenses
Selling General and Administrative
37,977
37,977
32,775
12,713
11,409
Total Operating Expenses
272,031
272,031
263,763
203,335
163,880
Operating Income or Loss
220,254
220,254
255,850
181,487
77,429
Interest Expense
667
667
606
669
806
Income Before Tax
220,408
220,408
257,967
182,628
72,581
Income Tax Expense
50,109
50,109
58,302
29,551
11,524
Income from Continuing Operations
170,299
170,299
199,665
153,077
61,057
Net Income
170,335
170,335
199,669
153,077
61,057
Net Income available to common shareholders
170,335
170,335
199,669
153,077
61,057
Basic EPS
3.73
3.29
3.73
2.76
1.10
Diluted EPS
3.73
3.29
3.73
2.76
1.10
Basic Average Shares
53,466
51,820
53,466
55,404
55,386
Diluted Average Shares
53,466
51,820
53,466
55,404
55,386